BridgeMD
New treatment option for Lung Neoplasms
Official title TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
ClinicalTrials.gov ID: NCT07165691
What this study is testing
- What it's testing
- Aim 1: Culturally adapt the TELESCOPE intervention for Hispanics. Using iterative qualitative feedback from a study-specific Community Advisory Board, focus groups, and interviews with community members, the investigators will culturally adapt the TELESCOPE intervention for Hispanics at high risk for lung cancer.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 77. Healthy volunteers may be eligible.
You may be able to join if
- Aim 1 (Cultural Adaptation): To be eligible, patients must:
- Identify as Hispanic and/or Latino(a)
- Able to read and speak in English or Spanish
- Be 50 to 77 years of age
- Be a current or former smoker
You likely can't join if
- For the cluster assigned by chance trial, excluded will be patients who:
- Do not speak English
- Are not Hispanic or Latino(a)
- Have a history of lung cancer
- Had a CT scan in the past 12 months
- Has been coughing up blood in the last two weeks
See the full eligibility criteria
- Aim 1 (Cultural Adaptation): To be eligible, patients must:
- Identify as Hispanic and/or Latino(a)
- Able to read and speak in English or Spanish
- Be 50 to 77 years of age
- Be a current or former smoker
- Have at least a 20-pack-year smoking history Aims 2-3 (Pilot assigned by chance Controlled Trial) To be eligible, patients must:
- Identify as Hispanic or Latino(a)
- Able to speak and read in English or Spanish
- Be 50 to 77 years of age
- Be a current or former smoker having quit within the past 15 years
- Have at least a 20 pack-year smoking history
- Be scheduled for a non-acute care visit at one of the study sites.
- Not coughing up blood in the last two weeks Interviews Providers completing the semi-structured interviews will be:
- A practicing primary care clinician or a clinic director (n=20), nursing director, or clinic practice administrator at one of the participating sites, or a TELESCOPE study patient navigator and nurse navigator
- Age 18 or older
- Fluent in English Online surveys Providers completing online PRISM construct surveys will be:
- A practicing primary care provider at one of the participating sites or a TELESCOPE study navigator
- Age 18 or older
- Fluent in English
- For the cluster assigned by chance trial, excluded will be patients who:
- Do not speak English
- Are not Hispanic or Latino(a)
- Have a history of lung cancer
- Had a CT scan in the past 12 months
- Has been coughing up blood in the last two weeks
- Have health conditions that make them poor candidates for curative treatment as determined by the primary care provider,
- Are unable to provide informed consent Interviews Providers/administrators will be excluded if they:
- Are unable to provide informed consent Online surveys
- Are unable to provide informed consent
- Women who are pregnant.
The study team makes the final eligibility decision.
Where it's taking place
- New Brunswick, New Jersey, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 77 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include New Brunswick, New Jersey, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.